Pituitary metastasis of hepatocellular carcinoma presenting with panhypopituitarism: a case report
Tomoko Tanaka(Tottori University), Yasunari Nakamoto(University of Fukui), Tomoyuki Nemoto(University of Fukui), Katsushi Hiramatsu(University of Fukui), Hidetaka Matsuda(University of Fukui), Hiroyuki Suto(University of Fukui), Kazuya Ofuji(Chiba Cancer Center), Kazuto Takahashi(University of Fukui), Tatsuya Yamamoto(Kansai University of Welfare Sciences), Tatsushi Naito(University of Fukui), Hirohiko Kimura(University of Fukui), Takuto Nosaka(University of Fukui), Yasushi Saitō(Chiba University), Masahiro Ohtani(University of Fukui)
Cited by 17
Related Papers
High-Dose Versus Low-Dose Pitavastatin in Japanese Patients With Stable Coronary Artery Disease (REAL-CAD)
|Circulation|2018|245
Phase II study of the GPC3-derived peptide vaccine as an adjuvant therapy for hepatocellular carcinoma patients
|OncoImmunology|2016|178
Essential contribution of a chemokine, CCL3, and its receptor, CCR1, to hepatocellular carcinoma progression
|International Journal of Cancer|2005|103
Hepatocyte Growth Factor and c-Met/Hepatocyte Growth Factor Receptor in Pulmonary Adenocarcinomas: An Evaluation of Their Expression as Prognostic Markers
|Oncology|2009|100
Aberrant expression of serine/threonine kinase Pim‐3 in hepatocellular carcinoma development and its role in the proliferation of human hepatoma cell lines
|International Journal of Cancer|2004|93